Eden Pharma announced the appointment of Mike Parker as Chief Operating Officer and director to the board. In this role, Parker will develop business models, execute new strategies and lead the company's marketing and finance functions.
"I am more than delighted to take on the role of COO at Eden Pharma," said Parker. "The opportunity laid out in the vision of Martin Booth and the company is immense for the cannabis industry. It pleases me greatly that the world will be able to see what benefits African-grown cannabis can offer, how the company will be able to create new products and value for partners everywhere."
An expert in emerging markets and business development, Parker is skilled in project management, sales process development and teambuilding. Having lived and worked in five countries, Parker is also experienced in entrepreneurship with a strong multicultural background. His primary entrepreneurial focus is on Medical Cannabis, Renewables, Defense and Continuous Improvement.
Eden Pharma is a developer and retailer of bespoke strains of marijuana for medical and recreational use. They are the 12th largest cannabis company according to Global Cannabis Times and the biggest in the UK and Europe. Eden Pharma is focused on research into cannabis to build a diverse portfolio of assets, including innovative medicinal and recreational applications.
